- Published at
- by manilatimes.net
neutral
neutral
News for Checkmate Pharmaceuticals, Inc. (CMPI)
- Published at
- by seekingalpha.com
positivepositiveLots Of Bullish Signals, But No Revenue Or Earnings From Tyra Biosciences (NASDAQ:TYRA)
Tyra Biosciences is a speculative play with potential for growth despite lack of revenue, focusing on precision medicines in oncology. See why TYRA is hold rated.- Published at
- by investing.com
neutralneutralSynOx Therapeutics announces $75m Series B round to fund Phase 3 trial of potential best-in-class treatment for TGCT By Investing.com
SynOx Therapeutics announces $75m Series B round to fund Phase 3 trial of potential best-in-class treatment for TGCT- Published at
- by globenewswire.com
mixedmixedAutolus Therapeutics Reports Second Quarter 2023 Financial Results and Operational Progress
Obe-cel, a potentially transformational treatment for relapsed/refractory (r/r) adult B-cell Acute Lymphoblastic Leukemia (ALL), on track for a Biologics...- Published at
- by marketscreener.com
mixedmixedAutolus Therapeutics announces appointment of Robert F. Dolski as Chief Financial Officer
- Veronica Hersberger appointed as Senior Vice President, Medical Affairs- Miranda Neville promoted to Senior Vice President, Project Management and will continue to lead the obe-cel program LONDON,...- Published at
- by marketscreener.com
mixedmixedRegeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
Fourth quarter 2022 revenues decreased 31% to $3.41 billion versus fourth quarter 2021; excluding REGEN-COV® and RonapreveTM, revenues increased 14%Full year 2022 revenues decreased 24% to $12.17... | February 3, 2023- Published at
- by gurufocus.com
positivepositiveMedicxi Ventures Management (Jersey) Ltd Buys 3, Sells 2 in 4th Quarter
GuruFocus Article or News written by insider and the topic is about:- Published at
- by globenewswire.com
mixedmixedXOMA Reports Third Quarter 2022 Financial Results and Highlights Recent Operational Events
Received first recurring royalty-style payment from Roche related to faricimab, its newly launched therapy for wet age-related macular degeneration (wAMD)...- Published at
- by seekingalpha.com
mixedmixedRGA Investment Advisors Q3 2022 Investment Commentary
For RGA Investment Advisors, the third quarter saw a continuation of the ugly trend from the first half of the year. Click here to read the full fund letter.- Published at
- by globenewswire.com
mixedmixedLongeveron Names Jerome Bailey Vice President of Business Operations
Executive brings more than 30 years of global biopharmaceutical operations and program management experience...- Published at
- by investing.com
mixedmixed- Published at
- by valuewalk.com
mixedmixed- Published at
- by etfdailynews.com
mixedmixedEquities Research Analysts’ Downgrades for April 20th (ACC, AGYS, ATRS, BBBY, CMPI, DUAVF, EGLE, FBBPF, GOGL, HAL)
Read Equities Research Analysts’ Downgrades for April 20th (ACC, AGYS, ATRS, BBBY, CMPI, DUAVF, EGLE, FBBPF, GOGL, HAL) at ETF Daily NewsYVXRT.MXVXRTVTXPFVSTAVMIVETVCT.LUFIUFCSTWODYTWODFTW.LTMHCTELLSWRBYSWRBFSWRAYSWRAFSUBCYSUBCO.OLSUBC.OLSTEM.LSSL.TOSSDSPXSYSPXSFSPX.LSITESHENSGPYYSGGEFSGE.LSFSHFSDFN.MXSDF1.DESDF.MISDF.DESANDSAFE.LRICKQUIKPENPDFSOTTROPIUSA.MXOPINLOPINIOPIOOMANUENTBNBSENB11.DEMYGNMRSNMRMDMOSMANLZLU2.DELITE.MXLITELGIHLFUSLCNBKPLUYKPLUFKMPHINVHHSBC.BAHSBC-PAHSBCHSBA.LHSB.PAHBCYFHBCN.MXHBC1.DEH1SB34.SAGOVATRSACGYF0VGM.L0LE3.L0JVV.L0JSI.L0A4Q.L0087.HK0019.HK0005.HKVSTOUBSN.MXUBSGEE.SWUBSGE.SWUBSG34.SAUBSG.SWUBSUBABTVTXTRVC.DETRIPTLKMFTLKTALN.MXTALT1LK34.SASMEDSLGCSBLKSAIARYRTRXPWRPNNTPLLPFXNLPFXPFLT.TAPFLTNTICNKTRNKSHNFLXNEMNDEKYNDEKFMRCMEECMCSLSCCKLR-WTKLRKGCJPSWYJAKKJITRGITR.VIAGHALDBN.MXDBK.PRDBK.MIDBK.DEDBCMIIWCMIIUCMIIC.MXC.BACBBBYAGYSACC6988.T0UNL.L0KT6.LWFCRMGBWRMGBURMGBPAVMWPAVMOPYMXDHFMDXH.BRMDJPMMLJPMCL.SNJPMC.BAJPMGOGLFIBRAPL14.MXFBBPFEGLEDUAVFCMPI0O8G.L- Published at
- by markets.businessinsider.com
mixedmixedThe Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ja...TPMR.MUTPMR.FTPMR.BETNXPSLNPRLDPRAHPMVPPGENPBYIOTICOCGNNGMMRNA.MXMRNAMASI.MXMASILIFEJAGXIMU.MUIMU.FIMU.DEIMU.BEIMGNIMABI5X.FGRTSGBIOFLGT.MXFLGTFATEF6T.FF6T.BEF2KA.FEO7.MUEO7.FEO7.BEENDPEIDXDMACCRISCMPIC6K.FBX2.MUBX2.FBX2.BEBTAIAIO.MUAIO.FAIO.BEABMD8PH.SG8PH.MU8PH.F8PH.BE7OT.MU7OT.F7F0.F7F0.BE471A.F471A.BE3M4.MU3M4.F3M4.BE2JQ.SG2JQ.MU2JQ.F2H51.F2H51.BE1JA2.SG1JA2.F1JA2.BE0VY.F0QF.SG0QF.MU0QF.F0QF.BE0PB.F0PB.BEZSANXTLBVVOSVTGNTCONT051.FT051.BEICPTI4P.MUI4P.FI4P.BEH2K2.SGH2K2.FH2K2.BECUSA.FCUSA.BECLPTCERCBNGO.MXBNGOBBIOBASIAVIRARVN2Y3.MU2Y3.BE2CL.MU2CL.F0ZPN.SG0ZPN.F0ZPN.BEUTHRUTH.SGUTH.MUUTH.FUTH.BEMYOVMRSNFDMTCALAAPRE71M.SG71M.F71M.BE2CB.F2CB.BE0M4.F0M4.BE